Home » Stocks » ABT

Abbott Laboratories (ABT)

Stock Price: $124.35 USD 0.41 (0.33%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
After-hours: $124.67 +0.32 (0.26%) Apr 16, 7:59 PM
Market Cap 220.29B
Revenue (ttm) 34.61B
Net Income (ttm) 4.50B
Shares Out 1.77B
EPS (ttm) 2.50
PE Ratio 49.68
Forward PE 24.81
Dividend $1.53
Dividend Yield 1.23%
Trading Day April 16
Last Price $124.35
Previous Close $123.94
Change ($) 0.41
Change (%) 0.33%
Day's Open 124.39
Day's Range 122.95 - 124.61
Day's Volume 6,243,068
52-Week Range 84.89 - 128.07

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

More than 300 publicly traded companies are expected to report March quarter earnings next week as earnings season revs up.

Other stocks mentioned: HOG, STLD, UAL
2 days ago - 24/7 Wall Street

Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.

Other stocks mentioned: AMEH, HSIC, NDRA, NTUS, OMI, PEN
2 days ago - Zacks Investment Research

Abbott stock is scheduled to report its Q1 2021 results on Tuesday, April 20. We expect Abbott to report revenues in-line and earnings above the consensus estimates, driven by continued demand for Covid...

2 days ago - Forbes

Abbott (ABT) closed at $123.01 in the latest trading session, marking a +1.63% move from the prior day.

5 days ago - Zacks Investment Research

Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 days ago - Zacks Investment Research

Two additional regulatory approvals in Europe are expected to have widened Abbott's (ABT) global Panbio customer base through Q1, contributing to the top line.

5 days ago - Zacks Investment Research

Per Abbott's (ABT) TRILUMINATE CE Mark study, the latest version shows sustained symptomatic improvement, reduction in the severity of TR and improvement in functional status.

6 days ago - Zacks Investment Research

ABBOTT PARK, Ill., April 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it is teaming up with Eliud Kipchoge, who is considered the world's fastest marathon runner, and the NN Running Team ...

6 days ago - PRNewsWire

Two elements will send revenue soaring in the coming months.

1 week ago - The Motley Fool

Abbott Laboratories (NYSE: ABT) won European approval for the latest generation of its TriClip system, a transcatheter-based repair device designed to stem leaks in the heart's tricuspid valve. The tric...

1 week ago - Benzinga

ABBOTT PARK, Ill., April 8, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark for its next-generation TriClip™ Transcatheter Tricuspid Valve Repair System, the first-of-its...

1 week ago - PRNewsWire

If you're going to buy individual stocks, why not buy your best ideas? Tracey explores what is the optimum number and how to find them.

Other stocks mentioned: AAPL, FB, GOOS
1 week ago - Zacks Investment Research

The studies by Abbott (ABT) show that DAPT can be safely discontinued early with no increased risk in patient adverse events.

1 week ago - Zacks Investment Research

Abbott Laboratories' (NYSE: ABT) XIENCE stent has received CE Mark in Europe for a shorter duration of dual antiplatelet therapy (DAPT) – as short as 28 days for patients with high bleeding risk (HBR). ...

1 week ago - Benzinga

ABBOTT PARK, Ill., April 6, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced its XIENCE stent has received CE Mark in Europe for shorter duration of dual anti-platelet therapy (DAPT) – as short a...

1 week ago - PRNewsWire

According to Abbott (ABT), the self-test BinaxNOW together with vaccines will help Americans get back to their regular daily work with greater confidence.

1 week ago - Zacks Investment Research

Investors remain optimistic about Abbott Laboratories (ABT) owing to strong growth in its molecular and rapid diagnostics business and progress in diabetes arm.

1 week ago - Zacks Investment Research

Abbott Labs looks attractive at current levels of $120, despite the stock rising 2x from levels of $62 it was at on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This...

1 week ago - Forbes

Abbott (ABT) closed the most recent trading day at $118.94, moving -0.75% from the previous trading session.

2 weeks ago - Zacks Investment Research

We have narrowed down our search to the following stocks, FLGT, BIO and IDXX based on a favorable Zacks Rank and strong prospects for 2021.

Other stocks mentioned: BDX, BIO, DGX, FLGT, IDXX
2 weeks ago - Zacks Investment Research

ABBOTT PARK, Ill., March 31, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non-p...

2 weeks ago - PRNewsWire

For a little less volatility and a little more dependability in 2021, check out these companies.

Other stocks mentioned: CVS, QDEL
2 weeks ago - The Motley Fool

Is (ABT) Outperforming Other Medical Stocks This Year?

2 weeks ago - Zacks Investment Research

ABBOTT PARK, Ill., March 29, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2021 financial results on Tuesday, April 20, 2021, before the market opens.

2 weeks ago - PRNewsWire

The next decade is poised to be one of the most influential in history.

Other stocks mentioned: LYFT, TDOC
3 weeks ago - The Motley Fool

These stocks should still be winners long after the pandemic is over.

Other stocks mentioned: JNJ, PFE
3 weeks ago - The Motley Fool

Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.

Other stocks mentioned: CSII, HOLX, HRC, IDXX, LH, LMAT
3 weeks ago - Zacks Investment Research

Grab these three top stocks - ABT, HOLX and BIO - that continue to show tremendous promise and stand to benefit from the historic stimulus package.

Other stocks mentioned: CAH, HOLX
3 weeks ago - Zacks Investment Research

Within Medical Device, Abbott (ABT) Diabetes Care business has been in the limelight for developments in its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.

3 weeks ago - Zacks Investment Research

Abbott (ABT) closed at $120.49 in the latest trading session, marking a -0.81% move from the prior day.

3 weeks ago - Zacks Investment Research

Here are a few diabetes-centric MedTech stocks, ABT, NVO, MDT, PODD and TNDM, which investors can focus on to reap profits in the new normal.

Other stocks mentioned: MDT, NVO, PODD, TNDM
4 weeks ago - Zacks Investment Research

The medical device company's stock generated 49% returns over just the past year.

4 weeks ago - The Motley Fool

The key words are "growth" and "recovery."

4 weeks ago - The Motley Fool

In the latest trading session, Abbott (ABT) closed at $117.62, marking a -0.51% move from the previous day.

1 month ago - Zacks Investment Research

Sit back, relax, and watch these stocks deliver.

Other stocks mentioned: AMZN, LULU
1 month ago - The Motley Fool

Is (ABT) Outperforming Other Medical Stocks This Year?

1 month ago - Zacks Investment Research

Tandem Diabetes (TNDM) is expects t:sport to be a major growth catalyst for 2022.

Other stocks mentioned: DXCM
1 month ago - Zacks Investment Research

Abbott (ABT) closed the most recent trading day at $117.52, moving +1.42% from the previous trading session.

1 month ago - Zacks Investment Research

ABBOTT PARK, Ill., March 11, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the formation of the Abbott Pandemic Defense Coalition, a first-of-its-kind global scientific and public health partn...

1 month ago - PRNewsWire

Abbott (ABT) stated that Medicare will cover remote programming services as a telehealth benefit through the duration of the public health emergency.

1 month ago - Zacks Investment Research

Abbott's (ABT) Alinity m SARS-CoV-2 test set to detect COVID-19 in individuals who do not have symptoms.

1 month ago - Zacks Investment Research

In the latest trading session, Abbott (ABT) closed at $117.25, marking a +1.07% move from the previous day.

1 month ago - Zacks Investment Research

The FDA has granted Emergency Use Authorization (EUA) for Abbott Laboratories' (NYSE: ABT) Alinity m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B, and res...

1 month ago - Benzinga

These four MedTech stocks -- ABT, JNJ, MDT and MASI -- are expected to gain enormously from FDA's SaMD Action Plan 2021.

Other stocks mentioned: JNJ, MASI, MDT
1 month ago - Zacks Investment Research

We believe that there are several stocks in the healthcare sector that are better than Abbott Labs. Abbott's current market cap-to-operating income ratio of 41x compares with 12x for Emergent Biosolutio...

1 month ago - Forbes

Abbott's (ABT) FreeStyle Libre is the only glucose sensing technology available in Canada to remotely monitor glucose status in an expectant mother to reduce exposure to COVID-19.

1 month ago - Zacks Investment Research

The pandemic won't always be a pandemic, but the virus is going to with us as an endemic part of life. That's the message from a new piece on Reuters.

Other stocks mentioned: APT, BNOW, QDEL
1 month ago - OTC PR Wire

Abbott Laboratories (NYSE: ABT) has announced a potential research breakthrough that could lead to advancements and potential vaccines for the treatment of HIV. What Happened: Abbott's researchers have ...

1 month ago - Benzinga

ABBOTT PARK, Ill., March 2, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that a team of scientists has found an unusually high number of people in the Democratic Republic of Congo (DRC) who t...

1 month ago - PRNewsWire

Abbott (ABT) possesses solid growth attributes, which could help it handily outperform the market.

1 month ago - Zacks Investment Research

About ABT

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidi... [Read more...]

Industry
Medical Devices
Founded
1888
CEO
Robert Ford
Employees
109,000
Stock Exchange
NYSE
Ticker Symbol
ABT
Full Company Profile

Financial Performance

In 2020, ABT's revenue was $34.61 billion, an increase of 8.48% compared to the previous year's $31.90 billion. Earnings were $4.50 billion, an increase of 21.91%.

Financial Statements

Analyst Forecasts

According to 21 analysts, the average rating for ABT stock is "Buy." The 12-month stock price forecast is 134.95, which is an increase of 8.52% from the latest price.

Price Target
$134.95
(8.52% upside)
Analyst Consensus: Buy